View Older Stories View More Recent Stories

Nov 15, 2017 04:43PM Form SC 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 14, 2017 04:42PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 13, 2017 04:35PM Form SC 13G SUNESIS PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 13, 2017 04:33PM Form SC 13D/A KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 13, 2017 09:05AM Ivantis FDA Clinical Trial of the Hydrus® Microstent for Minimally Invasive Glaucoma Surgery (MIGS) Meets Endpoints, Exceeds Outcomes of Past MIGS Trials
Nov 8, 2017 01:31PM InflaRX NV (Nasdaq: IFRX) to Ring The Nasdaq Stock Market Opening Bell
Oct 31, 2017 09:05AM Ivantis Completes Pre-Market Approval Submission for the Hydrus(TM) Microstent for Minimally Invasive Glaucoma Surgery (MIGS)
Oct 12, 2017 11:27AM Realm Therapeutics Announces Completion of $26 million Private Placement
Oct 11, 2017 08:38AM PlacementTracker Publishes Q3 2017 Private Placement Market League Tables
Sep 21, 2017 01:56PM Realm Therapeutics Announces $26 Million PIPE Financing
Aug 14, 2017 04:53PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 14, 2017 08:00AM Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Jul 10, 2017 08:45AM BioPharm America Offers More High-Level Opportunities for Networking With Global Life Science Executives at 2017 Edition
May 24, 2017 04:35PM Form 4 G1 Therapeutics, Inc. For: May 22 Filed by: RA CAPITAL MANAGEMENT, LLC
May 15, 2017 04:57PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
May 1, 2017 08:15AM Kala Pharmaceuticals Announces Positive Results from Confirmatory Phase 3 Trial of KPI-121 1% Following Cataract Surgery
May 1, 2017 02:45AM AB Science reports today its annual financials as of 31 December 2016 and provides an update on its activities
Apr 25, 2017 08:05AM Ivantis Announces FDA Clearance to Initiate Clinical Trial of the Hydrus(TM) Microstent for Minimally Invasive Glaucoma Surgery (MIGS) in Patients with Advanced Glaucoma
Apr 13, 2017 04:16PM Form SC 13D/A Dicerna Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Mar 30, 2017 07:00AM Solid Biosciences Raises up to $50 Million in Series C Financing
Mar 27, 2017 05:44PM Form 4 KalVista Pharmaceuticals For: Mar 23 Filed by: RA CAPITAL MANAGEMENT, LLC
Mar 8, 2017 08:30AM Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Mar 7, 2017 03:00AM Biohaven Closes Second Tranche Of Private Placement And Appoints Two New Directors To Board
Feb 16, 2017 04:05PM Form 13F-HR/A RA CAPITAL MANAGEMENT, For: Dec 31
Feb 16, 2017 04:03PM Form 13F-HR/A RA CAPITAL MANAGEMENT, For: Dec 31
Feb 15, 2017 09:11AM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Strongbridge Biopharma Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A SANUWAVE Health, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Protagonist Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A TENAX THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:10AM Form SC 13G/A Regulus Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A TG THERAPEUTICS, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A PROTEON THERAPEUTICS Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:09AM Form SC 13G/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:08AM Form SC 13G/A ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:08AM Form SC 13G/A DERMA SCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 15, 2017 07:08AM Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 06:12PM Form SC 13G/A Axovant Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 05:57PM Form SC 13G/A ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 05:51PM Form SC 13G/A AveXis, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 14, 2017 05:49PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 14, 2017 04:39PM Form SC 13D KalVista Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Jan 9, 2017 09:05AM Ivantis Raises $25 Million Series C to Fund Future US Commercialization of the Hydrus(TM) Microstent for Minimally Invasive Glaucoma Surgery (MIGS)
Jan 6, 2017 09:15AM Kala Pharmaceuticals to Present Update on Phase 3 Programs at the 35th Annual J.P. Morgan Healthcare Conference
Jan 5, 2017 10:13AM Satsuma Pharmaceuticals Spins Out from Shin Nippon Biomedical Laboratories (SNBL) with Funding from Leading Institutional Life Science Investors
Dec 23, 2016 04:16PM Form SC 13G AveXis, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
View More Recent Stories View Older Stories